Select for export Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2025.1594307 PubMed 40842948 Copy citation Copy BibTeX Frontiers in Psychiatry 2025-08-05 Grace Blest-Hopley, Giuseppe Pasculli, Simon Ruffell, WaiFung Tsang, Olateju Emmanuel, Kathryn M. Pate OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Between enhancement and risk: A critical review of psychedelic microdosing. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.copsyc.2025.102129 PubMed 40834796 Copy citation Copy BibTeX Unknown journal 2025-08-05 Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. Europe PMC Published psilocybin AnxietyMicrodosingReview Article Review Article More
Select for export Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fnsys.2025.1585367 PubMed 40894380 Copy citation Copy BibTeX Frontiers in Systems Neuroscience 2025-08-04 Dotun Adeleye Adeyinka, Dayna Forsyth, Suzanne Currie, Nicoletta Faraone OpenAlex Published psilocybin DepressionAddictionNeuroplasticity Other More
Select for export Response to emotional stimuli weaker in SSRI users compared with psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.31349 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2025-08-03 Authors unavailable OpenAlex Published psilocybin DepressionBrain ImagingMechanism of Action Clinical Trial More
Select for export Latent Classes of Lifetime Use of Seven Hallucinogens in the United States Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2025.2537040 PubMed 40760833 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2025-08-03 Meredith C. Meacham, Maha N. Mian, Ralph C. Wang, Allison R. Coker, B. Anderson, Juan Carlos C. Montoy OpenAlex Published psilocybin Receptor PharmacologyClinical TrialObservational Study Clinical Trial More
Select for export Therapeutic and legal aspects of psilocybin in cancer-related depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2025.1591864 PubMed 40831528 Copy citation Copy BibTeX Frontiers in Psychiatry 2025-08-03 Małgorzata Wierzbicka, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska OpenAlex Published psilocybinpsilocin DepressionAnxietyPTSD Clinical Trial More
Select for export 204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDER Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.019 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Bernard Lerer, Peretz Golding, Michal Brownstien, Adam Kozikowski, Tzuri Lifschytz OpenAlex Published psilocybin OCDReceptor PharmacologyAnimal Study Animal Study More
Select for export 577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.377 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Hiroe Tani OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export 544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.363 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola OpenAlex Published psilocybin DepressionNeuroplasticityPharmacology Animal Study More
Select for export 551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.368 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Bernard Lerer, Michal Brownstien, Mitchell A. Lazar, Peter A. Goldstein, Alexander Botvinnik, Alan P. Kozikowski OpenAlex Published psilocybin AnxietyOCDReceptor Pharmacology Animal Study More
Select for export 670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyaf052.159 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2025-07-31 Guy M. Goodwin OpenAlex Published psilocybin DepressionRandomized Controlled TrialTreatment-Resistant Depression Randomized Controlled Trial More
Select for export Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamine No abstract availability was recorded for this entry. Details DOI 10.1016/j.neuroscience.2025.05.064 Copy citation Copy BibTeX Neuroscience 2025-07-31 Mickaël Naassïla OpenAlex Published psilocybin AddictionReceptor PharmacologyAnimal Study Animal Study More
Select for export Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-025-06772-4 PubMed 40140019 Copy citation Copy BibTeX Psychopharmacology 2025-07-31 Ley L, Liechti ME, Becker AM, Straumann I, Klaiber A, Holze F PubMed Published psilocybin Healthy Volunteers Clinical Trial More
Select for export Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ajp.2025.104604 PubMed 40614615 Copy citation Copy BibTeX Asian journal of psychiatry 2025-07-31 Sulstarova A, Scheuerlein L, Monari S, Seragnoli F, Gabriel T, Preller K PubMed Published psilocybin Systematic ReviewReview ArticleSafety Systematic Review More
Select for export Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/fcp.70038 PubMed 40670864 Copy citation Copy BibTeX Unknown journal 2025-07-31 Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F Europe PMC Published psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Preparing Social Work for Psychedelic-Assisted Therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/sw/swaf031 PubMed 40803340 Copy citation Copy BibTeX Social Work 2025-07-29 Heidi Allen, B. Stott OpenAlex Published psilocybin DepressionPTSDMechanism of Action Clinical Trial More
Select for export Psilocybin-assisted treatment of depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.54905/disssi.v29i161.e110ms3657 Copy citation Copy BibTeX Medical Science 2025-07-29 Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus OpenAlex Published psilocybin DepressionReceptor PharmacologyReview Article Review Article More
Select for export Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation Retreat Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.07.30.25332422 Copy citation Copy BibTeX medRxiv 2025-07-29 Egger K, Meling D, Polat F, Seifritz E, Avram M, Scheidegger M. medRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingMechanism of ActionWellbeing Randomized Controlled Trial More
Select for export Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-7099164/v1 Copy citation Copy BibTeX Research Square 2025-07-26 Egger K, Bozsak R, Aicher H, Sari H, Poetzsch S, Rominger A Europe PMC PREPRINT (not peer reviewed) psilocybin Brain ImagingPharmacologyReceptor Pharmacology Other More
Select for export An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2025.111461 PubMed 40716639 Copy citation Copy BibTeX Unknown journal 2025-07-24 Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH Europe PMC Published psilocybin DepressionPTSDAddiction Review Article More